8-K

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934.

Date of Report (Date of earliest event reported) July 1, 2003

HCA INC.
(Exact name of registrant as specified in its charter)

DELAWARE
(State of Incorporation)

001-11239 (Commission File Number)	75-2497104 (IRS Employer Identification Number)
One Park Plaza, Nashville, Tennessee (Address of principal executive offices)	37203 (Zip Code)

(615) 344-9551
(Registrant’s telephone number, including area code)

TABLE OF CONTENTS

Ex-99 Press Release

ITEM 9.  REGULATION FD DISCLOSURE

     The following information is being furnished pursuant to Item 12 “Results of Operations and Financial Conditions.” On July 1, 2003, HCA Inc. issued a press release relating to court approval of settlement agreement, the text of which is set forth in Exhibit 99.

2

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

HCA Inc.

By: /s/ JOHN M. FRANCK II

John M. Franck II
Vice President and Corporate Secretary

DATED: July 2, 2003

3 EX-99 3 g83682exv99.txt EX-99 PRESS RELEASE EXHIBIT 99 HCA NEWS - -------------------------------------------------------------------------------- FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Jeff Prescott 615-344-2688 615-344-5708 HCA RECEIVES COURT APPROVAL OF SETTLEMENT AGREEMENT WITH DOJ, PAYS CMS SETTLEMENT NASHVILLE, TENN., JULY 1, 2003--HCA (NYSE-HCA) today announced that the U.S. District Court of the District of Columbia has approved a settlement agreement signed last week by the company and the U.S. Department of Justice. The agreement settled litigation brought by the DOJ against the company with respect to cost reports and physician relations. Under the settlement, which was originally announced in December 2002, HCA expects to pay the DOJ $631 million plus accrued interest before July 8, 2003. HCA also announced today that the company has paid the Centers for Medicare and Medicaid Services $250 million in accordance with an agreement, previously announced in March 2002 and signed last week, to resolve all Medicare cost report, home office cost statement, and appeal issues between HCA and CMS for cost report periods ending before Aug. 1, 2001. All references to "company" and "HCA" as used throughout this document refer to HCA Inc. and its affiliates. -----END PRIVACY-ENHANCED MESSAGE-----

EX-99

                                                                      EXHIBIT 99


HCA                                                        NEWS
- --------------------------------------------------------------------------------
                                                           FOR IMMEDIATE RELEASE


INVESTOR CONTACT:                                             MEDIA CONTACT:
Mark Kimbrough                                                Jeff Prescott
615-344-2688                                                  615-344-5708



                         HCA RECEIVES COURT APPROVAL OF
               SETTLEMENT AGREEMENT WITH DOJ, PAYS CMS SETTLEMENT


NASHVILLE, TENN., JULY 1, 2003--HCA (NYSE-HCA) today announced that the U.S.
District Court of the District of Columbia has approved a settlement agreement
signed last week by the company and the U.S. Department of Justice. The
agreement settled litigation brought by the DOJ against the company with respect
to cost reports and physician relations.

         Under the settlement, which was originally announced in December 2002,
HCA expects to pay the DOJ $631 million plus accrued interest before July 8,
2003.

         HCA also announced today that the company has paid the Centers for
Medicare and Medicaid Services $250 million in accordance with an agreement,
previously announced in March 2002 and signed last week, to resolve all Medicare
cost report, home office cost statement, and appeal issues between HCA and CMS
for cost report periods ending before Aug. 1, 2001.



All references to "company" and "HCA" as used throughout this document refer to
HCA Inc. and its affiliates.